ArticleBMC genomics2026
scFANCL: Dual contrastive learning with false-negative correction at cell level for single-cell RNA-seq clustering.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundSingle-cell RNA sequencing (scRNA-seq) enables cellular characterization at single-cell resolution. However, its high dimensionality, sparsity, and noise make clustering challenging. Approaches utilizing contrastive learning and data augmentation have been introduced to improve representation quality for scRNA-seq clustering. In particular, dual contrastive frameworks combining instance- and cluster-level objectives can capture both cell-cell similarities and inter-cluster variations. However, existing dual contrastive frameworks focus primarily on discrete cluster boundaries, neglecting the biological continuity inherent in scRNA-seq data.
methodsWe propose scFANCL, a dual contrastive framework designed to capture biological continuity in scRNA data. Rather than treating all non-augmented samples as negatives, scFANCL applies a cosine-similarity-based threshold to exclude cells of the same type from the negative pool, preserving continuous transcriptional relationships among them while maintaining inter-cluster separation.
resultsExtensive experiments across seven publicly available scRNA-seq datasets demonstrated that scFANCL achieves competitive clustering performance compared with existing baseline methods, consistently yielding high ARI and NMI scores across datasets of varying size and complexity. Ablation studies further confirmed the contribution of the false negative filtering component, showing measurable improvements over variants without filtering. Downstream analyses further suggest that the learned embeddings may reflect biologically meaningful transcriptional transitions, including continuous differentiation trajectories within related cell types. The source code is available at https://github.com/mjuailab/scFANCL .
conclusionsscFANCL addresses a key limitation of conventional contrastive learning by applying a cosine-similarity-based threshold to exclude cells of the same type from the negative pool, thereby preserving biological continuity within cell types while maintaining inter-cluster separation. Evaluations across seven benchmark scRNA-seq datasets demonstrate competitive clustering performance, with learned embeddings capturing biologically meaningful transcriptional structure and characteristics of rare cell populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.